Saltar al contenido

Bausch Health Companies Inc. (BHC) stock: revenue, earnings & dividend

Bausch Health Companies Inc. (BHC, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener BHC · NYSE Pharma & Biotech CA-QC

Key figures

Fiscal year
2025
Revenue
10.3 bn $
Revenue growth
6.7 %
Revenue growth 5y (p.a.)
5 %
Net income
157 m $
Net margin
1.5 %
Operating margin
17.7 %
Earnings per share (diluted)
0.42 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
26.4 bn $
Equity
-554 m $
Equity ratio
-2.1 %
Return on equity
–
Cash
1.31 bn $
Operating cash flow
1.4 bn $
Free cash flow
1 bn $
Shares outstanding
374,266,716

History

Revenue by fiscal year

2016 9.67 bn $
2017 8.72 bn $
2018 8.38 bn $
2019 8.6 bn $
2020 8.03 bn $
2021 8.43 bn $
2022 8.12 bn $
2023 8.76 bn $
2024 9.63 bn $
2025 10.3 bn $

Net income by fiscal year

2019 -1.79 bn $
2020 -560 m $
2021 -948 m $
2022 -225 m $
2023 -592 m $
2024 -46 m $
2025 157 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202510.3 bn $157 m $0.42 $–1.4 bn $
20249.63 bn $-46 m $-0.13 $–1.6 bn $
20238.76 bn $-592 m $-1.62 $–1.03 bn $
20228.12 bn $-225 m $-0.62 $–-728 m $
20218.43 bn $-948 m $-2.64 $–1.43 bn $
20208.03 bn $-560 m $-1.58 $–1.11 bn $
20198.6 bn $-1.79 bn $-5.08 $–1.5 bn $
20188.38 bn $–-11.81 $–1.5 bn $
20178.72 bn $–6.83 $–2.29 bn $
20169.67 bn $–-6.94 $–2.09 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)